Centaurus Financial Inc. lowered its position in The Cigna Group (NYSE:CI – Free Report) by 1.5% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,445 shares of the health services provider’s stock after selling 36 shares during the quarter. Centaurus Financial Inc.’s holdings in The Cigna Group were worth $847,000 at the end of the most recent quarter.
Other hedge funds also recently bought and sold shares of the company. Larson Financial Group LLC grew its position in The Cigna Group by 56.3% in the third quarter. Larson Financial Group LLC now owns 261 shares of the health services provider’s stock worth $90,000 after acquiring an additional 94 shares in the last quarter. Kingsview Wealth Management LLC boosted its holdings in The Cigna Group by 2.9% in the third quarter. Kingsview Wealth Management LLC now owns 31,572 shares of the health services provider’s stock worth $10,938,000 after purchasing an additional 886 shares in the last quarter. Cerity Partners LLC increased its position in The Cigna Group by 23.9% during the third quarter. Cerity Partners LLC now owns 108,520 shares of the health services provider’s stock worth $37,596,000 after buying an additional 20,926 shares during the last quarter. Great Valley Advisor Group Inc. raised its holdings in The Cigna Group by 3.5% during the third quarter. Great Valley Advisor Group Inc. now owns 8,227 shares of the health services provider’s stock valued at $2,850,000 after buying an additional 279 shares in the last quarter. Finally, Nicolet Advisory Services LLC lifted its position in shares of The Cigna Group by 13.5% in the third quarter. Nicolet Advisory Services LLC now owns 882 shares of the health services provider’s stock worth $300,000 after buying an additional 105 shares during the last quarter. 86.99% of the stock is owned by institutional investors and hedge funds.
The Cigna Group Stock Up 1.3 %
Shares of CI stock opened at $332.73 on Tuesday. The Cigna Group has a one year low of $253.95 and a one year high of $370.83. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.72 and a quick ratio of 0.72. The stock has a fifty day moving average price of $334.74 and a 200 day moving average price of $338.63. The stock has a market cap of $92.55 billion, a P/E ratio of 31.39, a price-to-earnings-growth ratio of 0.99 and a beta of 0.51.
The Cigna Group Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Thursday, December 19th. Stockholders of record on Wednesday, December 4th will be issued a $1.40 dividend. The ex-dividend date is Wednesday, December 4th. This represents a $5.60 dividend on an annualized basis and a dividend yield of 1.68%. The Cigna Group’s payout ratio is presently 52.83%.
Analysts Set New Price Targets
A number of research analysts have recently commented on the company. Stephens reissued an “overweight” rating and set a $410.00 price objective on shares of The Cigna Group in a report on Friday, November 1st. Jefferies Financial Group lifted their price target on shares of The Cigna Group from $402.00 to $422.00 and gave the company a “buy” rating in a research report on Tuesday, September 17th. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of The Cigna Group from $398.00 to $394.00 and set a “buy” rating for the company in a report on Monday, November 4th. JPMorgan Chase & Co. lifted their target price on shares of The Cigna Group from $435.00 to $438.00 and gave the stock an “overweight” rating in a report on Wednesday, August 21st. Finally, Barclays upped their price target on shares of The Cigna Group from $405.00 to $420.00 and gave the company an “overweight” rating in a report on Tuesday, November 5th. One research analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Buy” and a consensus price target of $394.64.
Get Our Latest Research Report on The Cigna Group
About The Cigna Group
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Featured Articles
- Five stocks we like better than The Cigna Group
- 3 Monster Growth Stocks to Buy Now
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- Short Selling: How to Short a Stock
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- Canada Bond Market Holiday: How to Invest and Trade
- Discover the 3 Best Performing Stocks That Went Public in 2024
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.